GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Jerusalem Pharmaceutical Co (XPAE:JPH) » Definitions » Scaled Net Operating Assets

Jerusalem Pharmaceutical Co (XPAE:JPH) Scaled Net Operating Assets : 0.69 (As of Dec. 2024)


View and export this data going back to 1997. Start your Free Trial

What is Jerusalem Pharmaceutical Co Scaled Net Operating Assets?

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

Jerusalem Pharmaceutical Co's operating assets for the quarter that ended in Dec. 2024 was $74.59 Mil. Jerusalem Pharmaceutical Co's operating liabilities for the quarter that ended in Dec. 2024 was $16.56 Mil. Jerusalem Pharmaceutical Co's Total Assets for the quarter that ended in Sep. 2024 was $84.31 Mil. Therefore, Jerusalem Pharmaceutical Co's scaled net operating assets (SNOA) for the quarter that ended in Dec. 2024 was 0.69.


Jerusalem Pharmaceutical Co Scaled Net Operating Assets Historical Data

The historical data trend for Jerusalem Pharmaceutical Co's Scaled Net Operating Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Jerusalem Pharmaceutical Co Scaled Net Operating Assets Chart

Jerusalem Pharmaceutical Co Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Scaled Net Operating Assets
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.90 0.85 0.69 0.75 0.67

Jerusalem Pharmaceutical Co Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Scaled Net Operating Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.75 0.72 0.70 0.69 0.69

Competitive Comparison of Jerusalem Pharmaceutical Co's Scaled Net Operating Assets

For the Drug Manufacturers - Specialty & Generic subindustry, Jerusalem Pharmaceutical Co's Scaled Net Operating Assets, along with its competitors' market caps and Scaled Net Operating Assets data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Jerusalem Pharmaceutical Co's Scaled Net Operating Assets Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Jerusalem Pharmaceutical Co's Scaled Net Operating Assets distribution charts can be found below:

* The bar in red indicates where Jerusalem Pharmaceutical Co's Scaled Net Operating Assets falls into.



Jerusalem Pharmaceutical Co Scaled Net Operating Assets Calculation

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

Jerusalem Pharmaceutical Co's Scaled Net Operating Assets (SNOA) for the fiscal year that ended in Dec. 2024 is calculated as

Scaled Net Operating Assets (SNOA)(A: Dec. 2024 )
=(Operating Assets (A: Dec. 2024 )-Operating Liabilities (A: Dec. 2024 ))/Total Assets (A: Dec. 2023 )
=(74.593-16.556)/86.321
=0.67

where

Operating Assets(A: Dec. 2024 )
=Total Assets - Cash, Cash Equivalents, Marketable Securities
=89.339 - 14.746
=74.593

Operating Liabilities(A: Dec. 2024 )
=Total Liabilities - Long-Term Debt & Capital Lease Obligation - Short-Term Debt & Capital Lease Obligation
=18.064 - 0.14 - 1.368
=16.556

Jerusalem Pharmaceutical Co's Scaled Net Operating Assets (SNOA) for the quarter that ended in Dec. 2024 is calculated as

Scaled Net Operating Assets (SNOA)(Q: Dec. 2024 )
=(Operating Assets (Q: Dec. 2024 )-Operating Liabilities (Q: Dec. 2024 ))/Total Assets (Q: Sep. 2024 )
=(74.593-16.556)/84.306
=0.69

where

Operating Assets(Q: Dec. 2024 )
=Total Assets - Cash, Cash Equivalents, Marketable Securities
=89.339 - 14.746
=74.593

Operating Liabilities(Q: Dec. 2024 )
=Total Liabilities - Long-Term Debt & Capital Lease Obligation - Short-Term Debt & Capital Lease Obligation
=18.064 - 0.14 - 1.368
=16.556

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Jerusalem Pharmaceutical Co Scaled Net Operating Assets Related Terms

Thank you for viewing the detailed overview of Jerusalem Pharmaceutical Co's Scaled Net Operating Assets provided by GuruFocus.com. Please click on the following links to see related term pages.


Jerusalem Pharmaceutical Co Business Description

Traded in Other Exchanges
N/A
Address
Nablus Street, Jerusalem Pharmaceuticals Company Buliding, Al Bireh Industrial Zone, Al Bireh, PSE, 3570
Jerusalem Pharmaceutical Co is engaged in developing, manufacturing and marketing of human pharmaceuticals products. It also produces detergent, cosmetic, personal and home care products, veterinary and agricultural products. The company operates in Jordan, Algeria, the Middle East, and North Africa Region. Its product portfolio contains more than 300 pharmaceutical products in various dosage forms including tablets, capsules, sterile injectables, powders for suspensions, suspensions, syrups, powders, suppositories, ovules, creams, ointments, as well as ear and nose drops and solutions.

Jerusalem Pharmaceutical Co Headlines

No Headlines